Neumora Therapeutics | 8-K: Current report
Neumora Therapeutics | 8-K: Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Neumora Therapeutics | DEF 14A: Definitive information statements
Neumora Therapeutics | DEFA14A: Others
Neumora Therapeutics | 8-K: Current report
Neumora Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Neumora Therapeutics | 8-K: Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Neumora Therapeutics | 8-K: Current report
Neumora Therapeutics | 8-K: Current report
Neumora Therapeutics | 8-K: Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Neumora Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Neumora Therapeutics | 8-K: Current report
Neumora Therapeutics, Inc. | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Neumora Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
No Data